克隆性血液形成,心血管疾病和癌症治疗引起的心脏毒性
Nan Zhang1, Xu Tian1, Dongkun Sun1
1Tianjin Key Laboratory of Ionic-Molecular Function of Cardiovascular Disease, Department of Cardiology, Tianjin Institute of Cardiology, Second Hospital of Tianjin Medical University, Tianjin 300211, China.
Seminars in cancer biology
|March 1, 2025
概括
克隆性血液形成 (CH) 是一种癌前状态,显著增加了癌症和心血管疾病 (CVD) 的风险. CH还会导致癌症治疗引起的心脏毒性,突出其在心脏瘤学中的作用.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 心脏病学 心脏病学
背景情况:
- 克隆性血液形成 (CH) 起源于单一的干细胞血统,增加癌症倾向.
- 心血管疾病与心血管疾病 (CVD) 发病率和死亡率越来越相关,与传统的风险因素相比.
- 在癌症幸存者中,CH在心血管疾病和心脏毒性中起作用,特别是来自抗癌疗法.
研究的目的:
- 审查CH,癌症和心血管疾病之间的联系.
- 专注于CH在抗癌治疗相关心脏毒性的作用.
- 提出未来的研究方向和临床实践方法.
主要方法:
- 文献综述和当前证据的综合.
- 分析CH对癌症患者和癌症幸存者的心血管健康的影响.
- 讨论将CH与心脏毒性联系在一起的机制.
主要成果:
- 冠状病毒是癌症和心血管疾病的重要危险因素.
- 抗癌治疗可以促进CH克隆扩张,加剧心脏毒性.
- 在心脏瘤学的新兴领域中,CH是关键因素.
结论:
- CH是心脏瘤学的关键参与者,影响癌症风险,心血管疾病和治疗毒性.
- 需要进一步的研究来阐明CH机制和临床影响.
- 建议采用系统方法将CH评估纳入临床实践.
相关概念视频
Regulation of Hematopoietic Stem Cells
3.1K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.1K
Bone Marrow Sampling and Transplants
270
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
270
Stem Cell Therapy for Tissue Regeneration
4.0K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.0K
Adaptive Mechanisms in Cancer Cells
5.7K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K
Cardiovascular Drugs: Classification based on Therapeutic Indications
2.0K
Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However,...
2.0K
Hematopoiesis
5.0K
The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...
5.0K


